COMMUNIQUÉS West-GlobeNewswire

Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders
17/02/2026
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“ Psyence BioMed ” or the “ Company ”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet [...]
Earth Science Tech, Inc. (ETST) Reports Third Fiscal Quarter 2026 Results
17/02/2026
Revenue of $8.4 million, up 14.1% year-over-year Gross profit margin of 76.3%, up 71 bps year-over-year Net income of $910,000, up 341% year-over-year Generated positive cash from operations of $1.2 million fiscal year- [...]
Serotonin Anti-Aging Centers Awards Five-Location Development Agreement for Dallas and Collin County
17/02/2026
Physician-Led Franchise Group Expands Brand’s Presence in the North Texas Market DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Serotonin Anti-Aging Centers , a national leader in science-backed longevity, hormone [...]
Novo Nordisk A/S: The European Commission approves more effective dose of injectable Wegovy® for adults with obesity; clinical study showed people lost about 21% of their body weight on average
17/02/2026
The European Commission has granted final approval of a higher 7.2 mg maintenance dose of Wegovy ® (semaglutide) for adults who may need extra help losing weight. It is now approved in all 27 countries in the European [...]
Casey House releases Big Fucking Deal, a short film examining the compounding effects of stigma for people living with HIV
17/02/2026
Study reveals only 44% of Canadians are confident that people living with HIV receive stigma-free health care when they need it – a gap the film recognizes through storytelling TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE [...]
Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices
17/02/2026
Buffalo, NY, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64-slice [...]
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
17/02/2026
Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced Pre-Market on February 18, 2026 NEW YORK, Feb. 17, [...]
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
17/02/2026
MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year [...]
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
17/02/2026
Adds to executive focus on early clinical development and deepens medical and scientific partnership with clients DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global [...]
Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
17/02/2026
In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had responded after 14 weeks of induction Duvakitug was well tolerated and safety [...]
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
17/02/2026
ALACHUA, Fla. and TAMPA, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, [...]
Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
17/02/2026
Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, [...]
AMT Medical Appoints Geert van Gansewinkel as CEO to Lead Company into Next Growth Phase Revolutionizing Coronary Artery Bypass Surgery
17/02/2026
www.amt-medical.nl https://vimeo.com/636954313 Anticipated Clinical Results on Graft Durability and Minimally Invasive Applications to Shape Company’s Future EDE/UTRECHT, The Netherlands – February 17, 2026 – AMT [...]
Oculis Appoints Katie Kazem as Chief Legal Officer
17/02/2026
Ms. Kazem brings extensive and global expertise in corporate governance and securities law, drawing on a distinguished track record as external legal counsel to leading life sciences companies Chief Legal Officer (CLO) [...]
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
17/02/2026
$107.1 million in 4Q VYJUVEK revenue and $730.3 million since U.S. launch FDA granted RMAT to KB707 for the treatment of advanced NSCLC and Fast Track Designation to KB111 for the treatment of HHD Strong balance sheet, [...]
Salipro Biotech Expands Global Intellectual Property Estate with Key U.S. Patent Grant
17/02/2026
New U.S. patent secures long term protection for the Salipro® platform technologies, extending exclusivity until 2042 and reinforcing the company’s position as a premier partner for drug discovery against challenging [...]
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
17/02/2026
ACTON, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics (NASDAQ: BJDX) today announced that it has successfully enrolled 545 patients in its SYMON™ II multicenter clinical study and has made substantial [...]
Communiqué de presse : Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva ont démontré une efficacité durable cliniquement significative dans la colite ulcéreuse et la maladie de Crohn
17/02/2026
Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva ont démontré une efficacité durable cliniquement significative dans la colite ulcéreuse et la maladie de Crohn Dans l’étude de phase IIb [...]
BioCryst to Present at Upcoming Investor Conference
17/02/2026
RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the T.D. Cowen 46 th Annual Health Care Conference in [...]

Pages